Trials / Completed
CompletedNCT04743986
The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- University of Calgary · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized controlled trial examining platelet rich plasma versus corticosteroid injection in partial thickness rotator cuff tears or tendinopathy.
Detailed description
We performed a randomized controlled trial on patients with imaging-shown rotator cuff tendinopathy or partial thickness tearing. Patients were randomized to receive either platelet rich plasma or corticosteroid. Follow-up was done at 6 weeks, 3 months and 12 months following injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Platelet Rich Plasma (PRP) | RegenLab, Lausanne, Switzerland |
| DRUG | Corticosteroid (CS) | 40mg/ml triamcinolone in 2 ml 0.5% bupivicaine |
Timeline
- Start date
- 2015-03-13
- Primary completion
- 2019-06-06
- Completion
- 2019-06-06
- First posted
- 2021-02-08
- Last updated
- 2021-02-08
Source: ClinicalTrials.gov record NCT04743986. Inclusion in this directory is not an endorsement.